Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): Synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex
JOURNAL OF MEDICINAL CHEMISTRY (2008)
期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 51, 期 4, 页码 737-751出版社
AMER CHEMICAL SOC
关键词
作者
我是这篇论文的作者
推荐
Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure
Josef Jansa, Radek Jorda, Jana Skerlova, Petr Pachl, Miroslav Perina, Eva Reznickova, Tomas Heger, Tomas Gucky, Pavlina Rezacova, Antonin Lycka, Vladimir Krystof
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation
Biruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo, Lianmeng Kou, Laychiluh Mekonnen, Yuchao Yang, Sunita K. C. Basnet, Ramin Hassankhani, Matthew J. Sykes, Mingfeng Yu, Shudong Wang
MOLECULES (2023)
Discovery of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies
Jianhang Huang, Xinren Wang, Ruinan Dong, Xiaoyue Liu, Hongmei Li, Tianyi Zhang, Junyu Xu, Chenhe Liu, Yanmin Zhang, Shaohua Hou, Weifang Tang, Tao Lu, Yadong Chen
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Hsa_circ_0000520 overexpression increases CDK2 expression via miR-1296 to facilitate cervical cancer cell proliferation
Qingling Zheng, Jin Zhang, Ting Zhang, Yanxiang Liu, Xiuluan Du, Xin Dai, Donghua Gu
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Allostery governs Cdk2 activation and differential recognition of CDK inhibitors
Abir Majumdar, David J. Burban, Joseph M. Muretta, Andrew R. Thompson, Tiffany A. Engel, Damien M. Rasmussen, Manu V. Subrahmanian, Gianluigi Veglia, David D. Thomas, Nicholas M. Levinson
NATURE CHEMICAL BIOLOGY (2021)
Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d] pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancer
Wei Wei, Zhanzhan Feng, Zhihao Liu, Xinyue Li, Hualong He, Kai Ran, Yaojie Shi, Yongxia Zhu, Tinghong Ye, Chao Gao, Ningyu Wang, Luoting Yu
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes
Lifei Wang, Dan Lu, Yan Wang, Xiaoyan Xu, Peihua Zhong, Zhiyong Yang
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)
Iridium-catalyzed C3-selective asymmetric allylation of 7-azaindoles with secondary allylic alcohols
Takahiro Sawano, Takeshi Matsui, Marina Koga, Eri Ishikawa, Ryo Takeuchi
CHEMICAL COMMUNICATIONS (2021)
Synergistic anticancer effect by targeting CDK2 and EGFR-ERK signaling
Jinhuan Wu, Yuping Chen, Rui Li, Yaping Guan, Mu Chen, Hui Yin, Xiaoning Yang, Mingpeng Jin, Bingsong Huang, Xin Ding, Jie Yang, Zhe Wang, Yiming He, Qianwen Wang, Jian Luo, Ping Wang, Zhiyong Mao, Michael S. Y. Huen, Zhenkun Lou, Jian Yuan, Fanghua Gong
JOURNAL OF CELL BIOLOGY (2023)
Discovery of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors
Alexander Sokolsky, Sarah Winterton, Keith Kennedy, Katherine Drake, Kristine Stump, Lu Huo, Yvonne Lo, Min Ye, Maryanne Covington, Sharon Diamond, Yan-ou Yang, Sunkyu Kim, Swamy Yeleswaram, Liangxing Wu, Wenqing Yao
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Discovery and identification of a novel PI3K inhibitor with enhanced CDK2 inhibition for the treatment of triple negative breast cancer
Chengbin Yang, Menghui Wang, Yimin Gong, Mingli Deng, Yun Ling, Qingquan Li, Jianxin Wang, Yaming Zhou
BIOORGANIC CHEMISTRY (2023)
Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N, N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer
Yuting Zhou, Xingwei Xu, Fei Wang, Huan He, Baohui Qi
BIOORGANIC CHEMISTRY (2021)
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells
Pamungkas Bagus Satriyo, Chih Ming Su, Jiann Ruey Ong, Wen-Chien Huang, Iat-Hang Fong, Chih-Cheng Lin, Teguh Aryandono, Sofia Mubarika Haryana, Li Deng, Chun-Chih Huang, Yew-Min Tzeng, Tsu-Yi Chao, Hui-Wen Liu, Chi-Tai Yeh
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
Design, Synthesis and Anticancer Profile of New 4-(1H-benzo[d]imidazol-1-yl)pyrimidin-2-amine-Linked Sulfonamide Derivatives with V600EBRAF Inhibitory Effect
Mohammed S. Abdel-Maksoud, Ahmed A. B. Mohamed, Rasha M. Hassan, Mohamed A. Abdelgawad, Garri Chilingaryan, Samy Selim, Mohamed S. Abdel-Bakky, Mohammad M. Al-Sanea
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement
Bernard Barlaam, Chris De Savi, Allan Dishington, Lisa Drew, Andrew D. Ferguson, Douglas Ferguson, Chungang Gu, Sudhir Hande, Lorraine Hassall, Janet Hawkins, Alexander W. Hird, Jane Holmes, Michelle L. Lamb, Andrew S. Lister, Thomas M. McGuire, Jane E. Moore, Nichole O'Connell, Anil Patel, Kurt G. Pike, Ujjal Sarkar, Wenlin Shao, Darren Stead, Jeffrey G. Varnes, Melissa M. Vasbinder, Lei Wang, Liangwei Wu, Lin Xue, Bin Yang, Tieguang Yao
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
Louise Conilh, Guy Fournet, Eric Fourmaux, Angelique Murcia, Eva-Laure Matera, Benoit Joseph, Charles Dumontet, Warren Viricel
PHARMACEUTICALS (2021)
Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines
Ariana Abawi, Xiaoyi Wang, Julien Bompard, Anna Berot, Valentina Andretto, Leslie Gudimard, Chloe Devillard, Emma Petiot, Benoit Joseph, Giovanna Lollo, Thierry Granjon, Agnes Girard-Egrot, Ofelia Maniti
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers
Amriti R. Lulla, Said Akli, Cansu Karakas, Min Jin Ha, Natalie W. Fowlkes, Yoshitsugu Mitani, Tuyen Bui, Jing Wang, Xiayu Rao, Kelly K. Hunt, Laurent Meijer, Adel K. El-Naggar, Khandan Keyomarsi
ONCOGENESIS (2021)
Polyamine-Conjugated Nitroxides Are Efficacious Inhibitors of Oxidative Reactions Catalyzed by Endothelial-Localized Myeloperoxidase
Sophie Maiocchi, Jacqueline Ku, Tom Hawtrey, Irene De Silvestro, Ernst Malle, Martin Rees, Shane R. Thomas, Jonathan C. Morris
CHEMICAL RESEARCH IN TOXICOLOGY (2021)
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study
Laurent Meijer, Genevieve Hery-Arnaud, Cyril Leven, Emmanuel Nowak, Sophie Hillion, Yves Renaudineau, Isabelle Durieu, Raphael Chiron, Anne Prevotat, Isabelle Fajac, Dominique Hubert, Marlene Murris-Espin, Sandrine Huge, Isabelle Danner-Boucher, Bruno Ravoninjatovo, Sylvie Leroy, Julie Macey, Thierry Urban, Gilles Rault, Dominique Mottier, Rozenn Le Berre
JOURNAL OF CYSTIC FIBROSIS (2022)
Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors
Tania Tahtouh, Emilie Durieu, Benoit Villiers, Celine Bruyere, Thu Lan Nguyen, Xavier Fant, Kwang H. Ahn, Leepakshi Khurana, Emmanuel Deau, Mattias F. Lindberg, Elodie Severe, Frederic Miege, Didier Roche, Emmanuelle Limanton, Jean-Martial L'helgoual'ch, Guillaume Burgy, Solene Guiheneuf, Yann Herault, Debra A. Kendall, Francois Carreaux, Jean-Pierre Bazureau, Laurent Meijer
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
Khadidja Bourahla, Solene Guiheneuf, Emmanuelle Limanton, Ludovic Paquin, Remy Le Guevel, Thierry Charlier, Mustapha Rahmouni, Emilie Durieu, Olivier Lozach, Francois Carreaux, Laurent Meijer, Jean-Pierre Bazureau
PHARMACEUTICALS (2021)
Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats
B. Souchet, M. Audrain, Y. Gu, M. F. Lindberg, N. S. Orefice, E. Rey, N. Cartier, N. Janel, L. Meijer, Jerome Braudeau
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2022)
Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy
Naseeb K. Malhi, Claire L. Allen, Elizabeth Stewart, Katherine L. Horton, Federica Riu, Jennifer Batson, Winfried Amoaku, Jonathan C. Morris, Kenton P. Arkill, David O. Bates
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2022)
Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer
Priyanka Gupta, Keehn Strange, Rahul Telange, Ailan Guo, Heather Hatch, Amin Sobh, Jonathan Elie, Angela M. Carter, John Totenhagen, Chunfeng Tan, Yogesh A. Sonawane, Jiri Neuzil, Amarnath Natarajan, Ashley J. Ovens, Jonathan S. Oakhill, Thorsten Wiederhold, Karel Pacak, Hans K. Ghayee, Laurent Meijer, Sushanth Reddy, James A. Bibb
CELL REPORTS (2022)
The protein kinase CK1: Inhibition, activation, and possible allosteric modulation
Yashoda Krishna Sunkari, Laurent Meijer, Marc Flajolet
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases
Mattias F. Lindberg, Emmanuel Deau, Jonas Arfwedson, Nicolas George, Pascal George, Patricia Alfonso, Ana Corrionero, Laurent Meijer
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B
Emmanuel Deau, Mattias F. F. Lindberg, Freideiric Miege, Didier Roche, Nicolas George, Pascal George, Andreas Kra''mer, Stefan Knapp, Laurent Meijer
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (vol 9, pg 480, 2022)
B. Souchet, M. Audrain, Y. Gu, M. F. Lindberg, N. S. Orefice, E. Rey, N. Cartier, N. Janel, L. Meijer, Jerome Braudeau
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2023)
Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (Jan, 10.14283/jpad.2022.18, 2022)
B. Souchet, M. Audrain, Y. Gu, M. F. Lindberg, N. S. Orefice, E. Rey, N. Cartier, N. Janel, L. Meijer, Jerome Braudeau
JOURNAL OF NUTRITION HEALTH & AGING (2022)